The Trump administration on Tuesday unveiled a health insurance option for small businesses and self-employed people that could lead to lower premiums but may a offer fewer benefits than current plans.
The Indianapolis-based system has spent $9 million on the “high-tech integrated service center,” but hopes to save up to $3 million a year through standardizing inventory, ordering in bulk at a discount, and streamlining delivery routes.
The investors in Scioto Biosciences include locally based Elevate Ventures, a private venture development organization; locally based BioCrossroads, a public-private collaboration that supports Indiana's life-sciences sector; and Ohio-based Rev1 Ventures.
Indiana spent $8.2 million in federal and state dollars in 2016 on programs to prevent people from smoking, help them quit, and protect people from secondhand smoke, the study said.
U.S. Health and Human Services Secretary Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.
Police say the demonstrators, some in wheelchairs, were arrested Sunday for trespassing after receiving several warnings.
As Marion County appears poised to launch a similar syringe-exchange program, public health officials point to a growing list of reports and studies they say proves such programs are a worthwhile investment.
Researchers from three universities, including Indiana University, have found that price competition in the generic drug market might be putting more patients at health risk due to a higher number of manufacturing-related product recalls.
The Indianapolis-based health system said it will continue to study possibilities for the land after neighbors objected to plans calling for nine buildings and four parking garages that carried an estimated price tag of $1 billion.
In a letter to the Indiana Department of Workforce Development, the company said “changing business needs require us to reduce operations at this facility.”
The Indianapolis-based drugmaker has been working for years to develop the much-anticipated drug, which some analysts had said might ring up $2 billion a year in sales.
Researchers at Indiana University and the Regenstrief Institute are measuring whether a virtual walk on the beach could help prevent cognitive issues faced by patients who spend time on a mechanical ventilation machine in the intensive care unit.
An Indianapolis-based company that makes handheld medical testing devices plans to move its 150 employees to a new headquarters in Boone County, where it will hire an additional 50 to 70 workers.
New therapies that could cure diseases caused by defective genes will get quicker approval from U.S. regulators, part of an effort by the Food and Drug Administration to keep pace with one of biotechnology’s fastest-growing fields.
President Donald Trump’s interest in the bill stems from a push by Vice President Mike Pence, who championed the initiative when he was governor of Indiana.
Brian Griffin, the leader of Anthem’s new PBM, IngenioRx, quit on May 8 with no warning to become CEO of Michigan-based Diplomat Pharmacy. Now Anthem is scrambling to adjust.
President Donald Trump is set to unveil his long-awaited plan for reducing drug prices after more than a year of bold promises to tackle pharmacy costs that are squeezing millions of Americans.
The Indianapolis-based pharmaceutical giant said it plans to acquire ARMO BioSciences Inc., which is working on treatments that activate the immune system of cancer patients to recognize and eradicate tumors.
The money is designed to further the work of Dr. Burcin Ekser and his team, who are working to print three-dimensional pig liver tissue from genetically engineered pig liver cells.
The ads for the metastatic breast cancer drug Verzenio show women in their 50s and 60s looking resolute and indomitable, surrounded by smiling friends and family.
